Autonomix Medical, Inc. — Investor Relations & Filings

Autonomix Medical, Inc. is a medical device company developing a platform technology for the diagnosis and treatment of diseases involving the peripheral nervous system. The company's core system enables real-time, intra-procedural nerve sensing and mapping to guide precision denervation. This minimally invasive, transvascular approach allows physicians to detect nerve activity, deliver targeted ablation therapy through the vessel wall, and immediately verify the disruption of nerve signals. The company's initial clinical focus is on interventional pain management for intractable pain associated with pancreatic and other visceral cancers. The platform is designed for potential expansion into other therapeutic areas, including cardiology, hypertension, and pulmonology.